Target intelligence / Profile preview

Apoptosis pathways in neurons

Molecular classification
Other
01

Overview

The term "apoptosis pathways in neurons" refers to the collection of molecular signaling processes that orchestrate programmed cell death in neuronal cells. These include: - The intrinsic (mitochondrial) pathway, regulated by pro- and anti-apoptotic BCL-2 family proteins and initiated by intracellular stresses (e.g., DNA damage, oxidative stress) leading to mitochondrial outer membrane permeabilization, cytochrome c release, apoptosome formation (APAF1 plus caspase-9), and activation of downstream effector caspases (mainly caspase-3 and caspase-7)[3][4][6]. - The extrinsic (death receptor) pathway, triggered by ligand binding (such as Fas ligand or TNF-α) to death domain-containing receptors (e.g., Fas receptor, TNF receptor, DR4, DR5), leading to assembly of death-inducing signaling complexes and initiation of the caspase cascade via caspase-8 or -10[1][3]. - Both pathways converge on a common set of effector caspases that enact the characteristic morphological and biochemical features of apoptosis, including DNA fragmentation, cell shrinkage, and membrane blebbing[1][2][3][4][6]. Dysregulation of these pathways is central to the pathology of many neurodegenerative diseases (due to excessive apoptosis) and brain cancers (due to evasion of apoptosis), as well as abnormal nervous system development if apoptosis is insufficient or excessive during key developmental windows[3][5][6][7]. Note: For pharmaceutical or mechanistic annotation, refer instead to individual molecular targets within these pathways, such as "Caspase-3", "BCL-2 family protein", or "Fas receptor" for proper structured metadata.

Other names
Apoptotic signaling pathways in neuronsNeuronal apoptosis pathwaysNeuronal programmed cell death pathways
02

Biological functions

ApoptosisCell deathNervous system developmentHomeostasis
03

Disease associations

Neurodegenerative diseaseCancer (specifically brain tumors such as glioblastoma, due to apoptosis resistance)Other developmental brain disorders
04

Safety considerations

Off-target induction of neuronal death (risk of cognitive or neurological impairment if apoptosis is triggered in healthy neurons)Inhibition of necessary developmental apoptosis (can result in abnormal nervous system architecture)Tumor resistance (inadequate apoptosis in cancer cells)
05

Biomarkers

Activated caspase-3Cleaved PARPCytochrome c releaseDNA fragmentation (TUNEL assay)

Beyond the preview

Go deeper on Apoptosis pathways in neurons.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apoptosis pathways in neurons.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call